Values Added Financial’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$608K Buy
900
+12
+1% +$7.13K 0.22% 71
2026
Q2
$445K Sell
888
-8
-0.9% -$3.84K 0.16% 90
2026
Q1
$440K Sell
896
-11
-1% -$5.97K 0.19% 77
2025
Q4
$526K Buy
907
+3
+0.3% +$1.7K 0.22% 75
2025
Q3
$438K Buy
904
+57
+7% +$26.5K 0.2% 78
2025
Q2
$343K Sell
847
-17
-2% -$7.11K 0.17% 90
2025
Q1
$430K Sell
864
-113
-12% -$61.2K 0.24% 74
2024
Q4
$508K Sell
977
-25
-2% -$13.7K 0.29% 64
2024
Q3
$620K Buy
1,002
+4
+0.4% +$2.37K 0.39% 44
2024
Q2
$552K Buy
998
+36
+4% +$20.6K 0.4% 46
2024
Q1
$559K Buy
962
+4
+0.4% +$2.24K 0.44% 47
2023
Q4
$508K Buy
958
+193
+25% +$93.4K 0.42% 43
2023
Q3
$387K Sell
765
-34
-4% -$18.1K 0.35% 54
2023
Q2
$417K Buy
+799
New +$431K 0.39% 52

Other funds holding TMO

Values Added Financial's TMO Position: Q3 2026 in Review

Values Added Financial increased its Thermo Fisher Scientific (TMO) stake by 1.4% in Q3 2026, buying an estimated $7.13K and bringing the position to 900 shares worth $608K. The position accounts for 0.22% of the portfolio, ranked #71.

Values Added Financial first reported a position in TMO in Q2 2023 and has held it in 14 quarters since. The position peaked at $620K in Q3 2024. 1,160 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Values Added Financial held 900 shares of Thermo Fisher Scientific worth $608K as of Q3 2026.
  • Values Added Financial bought 12 Thermo Fisher Scientific shares in Q3 2026, an estimated $7.13K.
  • Thermo Fisher Scientific made up 0.22% of Values Added Financial's portfolio in Q3 2026, its #71 holding.
  • Values Added Financial first reported a position in Thermo Fisher Scientific in Q2 2023 and has held it in 14 quarters since.
  • Values Added Financial's Thermo Fisher Scientific position peaked at $620K in Q3 2024.
  • 1,160 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Values Added Financial's 13F filing for Q3 2026, filed 28 Oct 2026.